Heterocyclic modulators of lipid synthesis
US-2024400552-A1 · Dec 5, 2024 · US
US12344594B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-12344594-B2 |
| Application number | US-202017116987-A |
| Country | US |
| Kind code | B2 |
| Filing date | Dec 9, 2020 |
| Priority date | Dec 9, 2019 |
| Publication date | Jul 1, 2025 |
| Grant date | Jul 1, 2025 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A compound of the following structure is provided:
Opening claim text (preview).
What is claimed is: 1. A compound of the following structure: wherein Q is selected from the group consisting of CH(alkyl), C(alkyl) 2 , NH, N(alkyl), O, S, SO 2 , Si(alkyl) 2 , P(O)(aryl), P(O)(alkyl), PO 2 H, PO 2 (alkyl), Se, and replaced with two H atoms; L is independently selected from the group consisting of O, OH, NH 2 , NH(alkyl), NH(deuterated alkyl), N(alkyl) 2 , N(deuterated alkyl) 2 , NH(aryl), N(aryl) 2 , N(alkyl)(aryl), N(deuterated alkyl) (aryl), substituted or unsubstituted cyclic amines with a ring size of 3, 4, 5, 6, 7, 8, or 9 atoms, and substituted or unsubstituted deuterated cyclic amines with a ring size of 3, 4, 5, 6, 7, 8, or 9 atoms, so long as when Q is O then L is not O or OH; R 1 , R 2 , R 3 , and R 4 are independently selected from the group consisting of H, D, halogen, CN, OH, O(alkyl), O(aryl), SH, S(alkyl), S(aryl), N 3 , NH 2 , NH(alkyl), N(alkyl) 2 , NH(aryl), N(aryl) 2 , NO 2 , CHO, C(O)(alkyl), C(O)(aryl), COOH, COO(alkyl), COO(aryl), C(O)NH(alkyl), C(O)NH(aryl), PO 3 H 2 , SO 3 H, alkyl and substituted alkyl, aryl and substituted aryl, alkenyl and substituted alkenyl, alkynyl or substituted alkynyl, or where each adjacent R substituent and L substituent, taken together with the carbon atoms to which they are bonded, independently form a substituted or unsubstituted ring containing 3, 4, 5, 6, 7, 8, or 9 atoms; X is selected from the group consisting of alkyl, substituted alkyl, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, CN, COOH, COO(alkyl), COO(aryl), C(O)NH(alkyl), C(O)N(alkyl) 2 , C(O)NH(aryl), and C(O)N(aryl) 2 ; when W is not present in the structure, Z is selected from the group consisting of H, halogen, OH, O(alkyl), O(aryl), COO, COOH, COO(alkyl), COO(aryl), C(O)NH(alkyl), C(O)N(alkyl) 2 , C(O)NH(aryl), C(O)N(aryl) 2 , PO 3 H 2 , SO 3 H, alkyl, substituted alkyl, alkenyl, and substituted alkenyl; and when W is present in the structure, Z is selected from the group consisting of C(O), SO 2 , PO 2 H, or CR 2 where each R is independently selected from the group consisting of H, alkyl, and substituted alkyl; and W is selected from the group consisting of O, S, C(O), C(N 2 ), NH, N(alkyl), N(aryl), N(SO 2 R) where R can be alkyl, substituted alkyl, or CN. 2. The compound of claim 1 , wherein X is selected from the group consisting of 3. The compound of claim 1 , wherein Q is selected from the group consisting of C(alkyl) 2 , O, S, SO 2 , Si(alkyl) 2 , P(O)(aryl), P(O)(alkyl), PO 2 H, and replaced with two H atoms. 4. The compound of claim 1 , wherein Q is selected from selected from the group consisting of and replaced with two H atoms. 5. The compound of claim 1 , wherein one or both L substituents are independently selected from the group consisting of O and OH. 6. The compound of claim 1 , wherein one or both L substituents are independently selected from the group consisting of NH 2 , NCH 3 (phenyl), NH(tert-butoxycarbonyl), and N(CH 3 ) 2 . 7. The compound of claim 1 , wherein one or both L substituents are independently selected from the group consisting of substituted or unsubstituted cyclic amines with a ring size of 4, 5, 6, 7, or 8 atoms. 8. The compound of claim 7 , wherein the substituted or unsubstituted cyclic amine with a ring size of 4, 5, 6, or 7 atoms is selected from the group consisting of 9. The compound of claim 1 , wherein the R 2 substituents, or the R 3 substituents, and L substituents are taken together with the carbon atoms to which they are bonded to form a substituted or unsubstituted ring containing 5, 6, 7, 8, or 9 atoms. 10. The compound of claim 1 , having a structure chosen from: wherein X is selected from the group consisting of alkyl, substituted alkyl, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, CN, COOH, COO(alkyl), COO(aryl), C(O)NH(alkyl), C(O)N(alkyl) 2 , C(O)NH(aryl), and C(O)N(aryl) 2 . 11. The compound of claim 10 , wherein X is selected from the group consisting of 12. A method for detecting a target substance, comprising: contacting a sample with the compound of claim 1 ; and detecting an emission light from the compound, the emission light indicating the presence of the target substance. 13. The method of claim 12 , wherein the target substance is selected from a protein, a carbohydrate, a polysaccharide, a glycoprotein, a hormone, a receptor, an antigen, an antibody, a virus, a substrate, a metabolite, an inhibitor, a drug, a nutrient, a growth factor, a liprotein, and a combination thereof. 14. The method of claim 12 , wherein the detecting step is performed with a microscope. 15. The method of claim 12 , wherein the contacting step and the detecting step are performed in a live cell. 16. The method of c
containing three or more hetero rings · CPC title
Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes" (in vivo A61B5/00; immunoassay G01N33/53) · CPC title
Fluorescence microscopy (fluorescence microscopes per se G02B21/0076 and G02B21/16) · CPC title
the condensed system containing one ring with oxygen as ring hetero atom and two rings with nitrogen as ring hetero atom · CPC title
containing three or more hetero rings · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.